Search

Search Results
Results 4671 - 4680 of 4687 for Movement Disorder
  • Lumakras
    Drug - 14 Jun 2022
    Consumer Medicine Information (CMI) about Lumakras intended for persons living in Australia.
  • Aratac
    Drug - 25 Jan 2022
    Consumer Medicine Information (CMI) about Aratac (amiodarone hydrochloride) intended for persons living in Australia.
  • DBL Promethazine Hydrochloride
    Drug - 18 Jan 2022
    Consumer Medicine Information (CMI) about DBL Promethazine Hydrochloride intended for persons living in Australia.
  • Metomax
    Drug - 10 Dec 2021
    Consumer Medicine Information (CMI) about Metomax (paracetamol & metoclopramide hydrochloride) intended for persons living in Australia.
  • Eraxis
    Drug - 15 Oct 2021
    Consumer Medicine Information (CMI) about Eraxis intended for persons living in Australia.
  • Amdarone
    Drug - 12 Oct 2021
    Consumer Medicine Information (CMI) about Amdarone (amiodarone hydrochloride) intended for persons living in Australia.
  • Buscopan 10mg tablets
    Drug - 28 Dec 2020
    Consumer Medicine Information (CMI) about Buscopan 10mg tablets intended for persons living in Australia.
  • Buscopan Injection
    Drug - 28 Dec 2020
    Consumer Medicine Information (CMI) about Buscopan Injection intended for persons living in Australia.
  • Buscopan Forte
    Drug - 28 Dec 2020
    Consumer Medicine Information (CMI) about Buscopan Forte intended for persons living in Australia.
  • Riamet
    Drug - 22 Jul 2020
    Consumer Medicine Information (CMI) about Riamet (Artemether and lumefantrine) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback